Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
---|---|---|---|---|---|---|---|---|---|---|---|
INBX | Inhibrx, Inc. | Eckelman Brendan P. | Chief Scientific Officer | Feb 01, 2023 | Sale | $24.73 | 28,750 | 710,856 | 2,102,104 | Feb 02, 2023, 07:26 PM | |
INBX | Inhibrx, Inc. | Eckelman Brendan P. | Chief Scientific Officer | Feb 02, 2023 | Sale | $25.45 | 11,250 | 286,355 | 2,076,683 | Feb 02, 2023, 07:26 PM | |
INBX | Inhibrx, Inc. | Eckelman Brendan P. | Chief Scientific Officer | Jan 03, 2023 | Sale | $23.77 | 32,895 | 781,770 | 2,133,340 | Jan 04, 2023, 05:53 PM | |
INBX | Inhibrx, Inc. | Eckelman Brendan P. | Chief Scientific Officer | Jan 04, 2023 | Sale | $23.48 | 7,105 | 166,829 | 2,118,556 | Jan 04, 2023, 05:53 PM | |
INBX | Inhibrx, Inc. | Eckelman Brendan P. | Chief Scientific Officer | Dec 06, 2022 | Sale | $27.22 | 40,000 | 1,088,683 | 2,174,626 | Dec 07, 2022, 04:30 PM | |
INBX | Inhibrx, Inc. | Eckelman Brendan P. | Chief Scientific Officer | Nov 01, 2022 | Sale | $33.51 | 40,000 | 1,340,387 | 2,207,902 | Nov 02, 2022, 05:04 PM | |
INBX | Inhibrx, Inc. | Eckelman Brendan P. | Chief Scientific Officer | Oct 04, 2022 | Sale | $27.82 | 40,000 | 1,112,813 | 2,274,105 | Oct 05, 2022, 04:15 PM | |
INBX | Inhibrx, Inc. | Eckelman Brendan P. | Chief Scientific Officer | Sep 06, 2022 | Sale | $14.91 | 40,000 | 596,274 | 2,438,046 | Sep 07, 2022, 04:57 PM | |
INBX | Inhibrx, Inc. | Eckelman Brendan P. | Chief Scientific Officer | Aug 02, 2022 | Sale | $17.70 | 24,500 | 433,625 | 2,491,053 | Aug 04, 2022, 04:33 PM | |
INBX | Inhibrx, Inc. | Eckelman Brendan P. | Chief Scientific Officer | Aug 03, 2022 | Sale | $18.47 | 15,500 | 286,209 | 2,475,553 | Aug 04, 2022, 04:33 PM | |
INBX | Inhibrx, Inc. | Eckelman Brendan P. | Chief Scientific Officer | Jul 07, 2022 | Sale | $17.17 | 40,000 | 686,800 | 2,515,553 | Jul 08, 2022, 04:03 PM | |
INBX | Inhibrx, Inc. | Eckelman Brendan P. | Chief Scientific Officer | Apr 05, 2022 | Sale | $25.04 | 400 | 10,016 | 2,555,553 | Apr 07, 2022, 04:11 PM | |
INBX | Inhibrx, Inc. | Eckelman Brendan P. | Chief Scientific Officer | Mar 24, 2021 | Sale | $19.02 | 17,000 | 323,340 | 2,555,953 | Mar 24, 2021, 07:12 PM | |
INBX | Inhibrx, Inc. | Eckelman Brendan P. | Chief Scientific Officer | Feb 16, 2021 | Sale | $25.90 | 17,000 | 440,300 | 2,572,953 | Feb 18, 2021, 05:08 PM |